4.7 Review

Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches

Journal

NATURE REVIEWS GENETICS
Volume 14, Issue 6, Pages 373-378

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrg3460

Keywords

-

Funding

  1. UK Medical Research Council
  2. Wellcome Trust
  3. UK Muscular Dystrophy Campaign
  4. US Muscular Dystrophy Association
  5. Action Duchenne
  6. Association Francaise Contre les Myopathies
  7. International Consortium on Exon Skipping
  8. Medical Research Council [MC_UU_12021/2, G0900887, G0801763] Funding Source: researchfish
  9. Rosetrees Trust [M164-F1] Funding Source: researchfish
  10. MRC [G0900887, MC_UU_12021/2, G0801763] Funding Source: UKRI

Ask authors/readers for more resources

Duchenne muscular dystrophy (DMD) is a devastating progressive disease for which there is currently no effective treatment except palliative therapy. There are several promising genetic approaches, including viral delivery of the missing dystrophin gene, read-through of translation stop codons, exon skipping to restore the reading frame and increased expression of the compensatory utrophin gene. The lessons learned from these approaches will be applicable to many other disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available